BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/7/2025 1:45:06 AM | Browse: 12 | Download: 0
Category |
Cell & Tissue Engineering |
Manuscript Type |
Review |
Article Title |
Challenges in the clinical translation of stromal vascular fraction therapy in regenerative medicine
|
Manuscript Source |
Invited Manuscript |
All Author List |
Naveen Jeyaraman, Sandeep Shrivastava, Ravi Velamoor Rangarajan, Arulkumar Nallakumarasamy, Swaminathan Ramasubramanian, Avinash Gandi Devadas, Secunda Rupert and Madhan Jeyaraman |
Funding Agency and Grant Number |
|
Corresponding Author |
Madhan Jeyaraman, Department of Orthopaedics, ACS Medical College and Hospital, Dr MGR Educational and Research Institute, Velappanchavadi, Chennai 600077, Tamil Nadu, India. madhanjeyaraman@gmail.com |
Key Words |
Stromal vascular fraction; Regenerative medicine; Cell therapy; Clinical translation; Adipose-derived stem cells |
Core Tip |
Stromal vascular fraction (SVF) therapy, derived from adipose tissue and containing a mix of cells, shows promise in treating conditions like osteoarthritis and chronic wounds. However, challenges such as biological variability, unclear mechanisms, regulatory issues, and scalability hinder clinical translation. Addressing these requires technological advancements, regulatory flexibility, and interdisciplinary collaboration. Innovations like automated isolation, advanced biomaterials, and CRISPR-based editing could enhance reliability. A structured roadmap, including preclinical research and large-scale trials, is essential for advancing SVF therapies. Future efforts should focus on standardizing protocols and generating real-world evidence to maximize SVF’s potential in regenerative medicine. |
Citation |
Jeyaraman N, Shrivastava S, Rangarajan RV, Nallakumarasamy A, Ramasubramanian S, Devadas AG, Rupert S, Jeyaraman M. Challenges in the clinical translation of stromal vascular fraction therapy in regenerative medicine. World J Stem Cells 2025; In press |
 |
Received |
|
2024-12-03 15:31 |
 |
Peer-Review Started |
|
2024-12-06 00:16 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-02-14 08:37 |
 |
Revised |
|
2025-03-13 08:47 |
 |
Second Decision |
|
2025-04-22 01:10 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-07 01:45 |
 |
Articles in Press |
|
2025-05-07 01:45 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345